-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - December 2007 regarding the possible association of the
use of pamidronate with deterioration of renal … • Renal function:
m Evidence is insufficient from trials assessing
the effect of renal function … Two trials
report no effect of renal function on the effects of
these agents. … However, in a third trial, impaired
renal function reduced the efficacy of zoledronic
acid in preventing … Insufficient
Evidence is inconclusive on the effects of renal function on the efficacy of alendronate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - of antidiabetic drugs
2
Metformin is also frequently avoided
in older adults due to declines in
renal … sulfonylurea use in older
adults is associated with increased risk
of hypoglycemia also due to decreasing
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
February 01, 2021 - or conditions (e.g., advanced heart failure, chronic obstructive pulmonary disease, or end-
stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - other
musculoskeletal pain, neuropathic pain, postsurgical
pain, dental pain, pain associated with renal … for
several acute pain conditions including postoperative
pain, dental pain, neck pain, back pain, renal … of systematic
reviews include postoperative postdischarge pain,
acute back pain, acute neck pain, renal … a
new systematic review: pain associated with dental
procedures and oral surgery, low back pain, renal … Evidence Gaps
Study Populations
• Updated comprehensive assessment of the
evidence related to renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - Transferrin receptor assay and
zinc protoporphyrin as markers of iron-deficient erythropoiesis in
end-stage renal … Reticulocyte indices
in patients with end stage renal disease on hemodialysis. … Contribution of iron
deficiency to anemia in chronic renal failure. … to serum ferritin
(ZPP/logSF index) in the detection of iron deficiency in patients
with end-stage renal … Markers of masked iron
deficiency and effectiveness of EPO therapy in chronic renal
failure.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
December 16, 2011 - be idiopathic or primary RLS, or secondary to other conditions such as iron
deficiency, end-stage renal … (age, gender, race, comorbidities, disease severity,
etiology, iron status, pregnancy, end-stage renal … Studies that include individuals with RLS comorbid with iron deficiency,
pregnancy, or end-stage renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
January 01, 2016 - regulation; medication adherence; or self-
monitoring for diabetic complications (foot exam, eye
exam, and renal
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-radiation-therapy-bone-metastases.pdf
August 01, 2022 - found that the incidence of bone metastases in individuals with prostate cancer, breast
cancer, and renal … with bone metastases, the
incidence of bone metastasis in individuals with
prostate, breast, and renal … with bone metastases, the
incidence of bone metastasis in individuals with
prostate, breast, and renal
-
effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
January 01, 2012 - .”
The most common concern of physicians treating diabetes is
“renal
failure.”
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
October 01, 2018 - was no difference between IOCM and LOCM for secondary outcomes, such as cardiac
events, need for renal … Main Outcomes:
• contrast-induced nephropathy (CIN)
• Secondary outcomes: patient characteristics (renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - (Hoffmann-La
Roche)
IL-2 Prophylaxis of acute organ rejection in patients
receiving renal transplants … Adjunct for the prevention of rejection in renal
homotransplantation; management of active
rheumatoid … (Hoffmann-La
Roche)
Prophylaxis of organ rejection in patients receiving
allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving
allogeneic renal, cardiac, or hepatic transplants
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
May 01, 2013 - shares similar risk factors: male gender,
age, diabetes, smoking, hypertension, high
cholesterol, and renal … Subgroups reported included age (three studies), symptom
class (three studies), renal failure (two studies … from the observational
studies had a high likelihood of bias but did show that
with advanced age, renal … two RCTs,
four observational) in the mixed IC-CLI population
reported harms of bleeding, infection, renal … An
observational study showed worse survival in advanced age,
renal failure, and with higher PAD severity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
November 09, 2011 - www.effectivehealthcare.ahrq.gov
Published Online: November 9, 2011
Interventions to prevent contrast-induced renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
August 23, 2013 - risk prediction tools, including testing and
validating the use of newer clinical markers (such as renal … ) medication and procedural interventions in specific subpopulations
(e.g., patients with advanced renal … Peer Reviewer
#2
ES (Results) The final bullet on page ES-17 states: “Patients with
renal impairment … This finding is based on
one study of patients with renal impairment, two
studies of patients with … Recommendation: Include a separate
key point for patients with renal impairment, and
specify that these
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
May 29, 2025 - unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal … unless otherwise contraindicated for populations represented by Medicare, (e.g., seniors or patients in renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - Expert
#4
ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe
renal … major decision maker in this section, or if it stays in, specify
that the contraindication is severe renal … evidence summary does not include information on the
potential contraindications of acamprosate (severe renal … should be careful to respect contraindications of each individual medication (for
acamprosate, severe renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
October 03, 2019 - health requirements (e.g., status of HbA1c, diabetes, peripheral vascular disease,
obesity, smoking, renal … and general health
(e.g., status of HbA1c, diabetes, peripheral vascular disease, obesity, smoking, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - Toxicity was more likely with
MTX in patients with greater renal
impairment. … Those with high risk comorbidities
(cardiovascular events, diabetes,
malignancies, renal impairment … Toxicity was more likely
with MTX in patients with greater renal impairment. … New Evidence:
Those with highrisk comorbidities (cardiovascular events,
diabetes, malignancies, renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - Toxicity was more likely with
MTX in patients with greater renal
impairment. … Those with high risk comorbidities
(cardiovascular events, diabetes,
malignancies, renal impairment … Toxicity was more likely
with MTX in patients with greater renal impairment. … New Evidence:
Those with highrisk comorbidities (cardiovascular events,
diabetes, malignancies, renal
-
effectivehealthcare.ahrq.gov/products/nephropathy-contrast-induced/research-protocol